HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiro Ishikawa Selected Research

ethylenediamine (ethylenediamine dihydroiodide)

3/2018Treatment of oral cancer using magnetized paclitaxel.
8/2017The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity.
1/2017Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment.
1/2016Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles.
3/2015A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiro Ishikawa Research Topics

Disease

19Heart Failure
01/2020 - 08/2003
16Neoplasms (Cancer)
05/2021 - 08/2007
7Cardiomyopathies (Cardiomyopathy)
01/2021 - 11/2004
7Hyperthermia
01/2019 - 05/2012
6Vascular Remodeling
03/2017 - 09/2007
6Hypertrophy
05/2016 - 12/2002
5Melanoma (Melanoma, Malignant)
07/2017 - 10/2009
5Cardiomegaly (Heart Hypertrophy)
12/2014 - 12/2003
4Osteogenesis Imperfecta (Lobstein Disease)
01/2021 - 05/2010
4Abdominal Aortic Aneurysm
01/2020 - 01/2012
4Reperfusion Injury
09/2014 - 01/2008
4Ischemia
04/2014 - 08/2003
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2009 - 12/2002
3Fibrosis (Cirrhosis)
01/2020 - 04/2013
3Neointima
06/2019 - 09/2007
3Cardiac Arrhythmias (Arrythmia)
01/2019 - 01/2016
3Hypertension (High Blood Pressure)
03/2017 - 01/2003
3Heart Diseases (Heart Disease)
01/2017 - 03/2009
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2016 - 11/2004
3Vascular Ring
07/2014 - 09/2009
3Hypoxia (Hypoxemia)
01/2014 - 01/2008
2Idiopathic Pulmonary Fibrosis
01/2022 - 01/2017
2Adenocarcinoma of Lung
03/2021 - 12/2017
2Hearing Loss (Hearing Impairment)
01/2020 - 06/2014
2Aortic Rupture
01/2020 - 06/2014
2Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
01/2020 - 06/2014
2Inflammation (Inflammations)
01/2020 - 10/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2019 - 01/2017
2Mouth Neoplasms (Oral Cancer)
03/2018 - 05/2014
2Septic Shock (Toxic Shock Syndrome)
01/2018 - 01/2017
2Aortic Aneurysm (Aneurysm, Aortic)
03/2017 - 01/2012
2Pathologic Constriction (Stenosis)
03/2017 - 01/2012
2Tongue Neoplasms (Tongue Neoplasm)
01/2017 - 01/2016
2Hypertrophy of Masticatory Muscles
05/2016 - 12/2014
2Infarction (Infarctions)
09/2014 - 01/2008
2Pain (Aches)
12/2013 - 01/2012
2Congenital Heart Defects (Congenital Heart Defect)
01/2012 - 06/2010
2Insulin Resistance
03/2010 - 08/2004
2Bradycardia
02/2007 - 08/2003
1Rupture
08/2021
1Atherosclerosis
07/2021
1Neuroendocrine Carcinoma
05/2021

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2007
12Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2018 - 01/2003
11erythromycin propionate-N-acetylcysteinateIBA
01/2019 - 09/2007
8CatecholaminesIBA
01/2018 - 10/2007
6mu-oxo N,N'- bis(salicylidene)ethylenediamine ironIBA
01/2019 - 03/2015
6Pharmaceutical PreparationsIBA
03/2018 - 06/2012
6Isoproterenol (Isoprenaline)FDA LinkGeneric
12/2014 - 08/2003
6Caveolin 3IBA
09/2014 - 12/2002
5ethylenediamine (ethylenediamine dihydroiodide)FDA Link
03/2018 - 03/2015
5IronIBA
03/2018 - 03/2015
4CytokinesIBA
01/2020 - 01/2012
4Messenger RNA (mRNA)IBA
01/2020 - 04/2006
4Adrenergic Agents (Adrenergic Drugs)IBA
01/2015 - 11/2004
4Protein Isoforms (Isoforms)IBA
12/2014 - 01/2003
4Phenylephrine (Neo-Synephrine)FDA LinkGeneric
07/2014 - 08/2003
4Prostaglandins EIBA
01/2012 - 11/2006
3CollagenIBA
08/2021 - 01/2017
3Biomarkers (Surrogate Marker)IBA
07/2021 - 01/2012
3Myosin Heavy Chains (Myosin Heavy Chain)IBA
07/2021 - 12/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2019
3Vidarabine (Vira-A)FDA Link
01/2018 - 06/2012
3Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2014 - 08/2007
3Hyaluronic Acid (Hyaluronan)IBA
01/2012 - 09/2007
3CaveolinsIBA
03/2010 - 12/2002
3beta Adrenergic ReceptorsIBA
02/2009 - 08/2003
2Tacrolimus Binding Proteins (FKBP)IBA
01/2022 - 01/2020
2Collagen Type I (Type I Collagen)IBA
01/2021 - 05/2010
2FKBP22IBA
01/2020 - 06/2014
2Adrenergic Receptors (Adrenergic Receptor)IBA
01/2019 - 03/2015
2MetalsIBA
08/2017 - 03/2015
2disalicylaldehyde ethylenediamine (salen)IBA
08/2017 - 03/2015
2Histone Deacetylases (Histone Deacetylase)IBA
05/2016 - 12/2014
2Calcium-Calmodulin-Dependent Protein KinasesIBA
05/2016 - 12/2014
2Cyclic AMP (AMP, Cyclic)IBA
05/2016 - 12/2014
2ClenbuterolIBA
05/2016 - 12/2014
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
05/2016 - 12/2014
2ferric oxide (iron oxide)IBA
01/2016 - 05/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2015 - 05/2012
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2015 - 11/2004
2TroponinIBA
09/2014 - 01/2008
2Angiotensin IIIBA
09/2014 - 02/2009
2cyclophilin BIBA
06/2014 - 06/2012
2Anesthetics (Anesthetic Agents)IBA
04/2014 - 01/2008
2GTP-Binding Proteins (G-Protein)IBA
01/2014 - 11/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 05/2011
2Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
01/2014 - 05/2011
2Connexin 43 (Connexin43)IBA
01/2014 - 11/2009
2Sirtuin 1IBA
07/2013 - 04/2013
2Insulin (Novolin)FDA Link
03/2010 - 08/2004
2Vasodilator Agents (Vasodilators)IBA
02/2009 - 11/2006
2ColforsinIBA
09/2006 - 08/2003
2Glucose (Dextrose)FDA LinkGeneric
08/2004 - 10/2002
1Tumor Biomarkers (Tumor Markers)IBA
05/2021
1amrubicinIBA
05/2021
1ElementsIBA
03/2021

Therapy/Procedure

17Therapeutics
07/2019 - 10/2007
11Drug Therapy (Chemotherapy)
01/2019 - 08/2007
2Induced Hyperthermia (Thermotherapy)
01/2016 - 05/2014